PARP1 and neuroblastoma: Effective combined treatment with an approved PARP inhibitor and other inhibitors of DDR/DNA damage checkpoints proteins, including ATR, CHK1, and DNA-PK, or other combinations, might improve the specific killing of neuroblastomas harboring 11q loss (Figure 3B).